
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC
Sheena Suthen, Chun Jye Lim, Phuong H. D. Nguyen, et al.
Hepatology (2022) Vol. 76, Iss. 5, pp. 1329-1344
Open Access | Times Cited: 115
Sheena Suthen, Chun Jye Lim, Phuong H. D. Nguyen, et al.
Hepatology (2022) Vol. 76, Iss. 5, pp. 1329-1344
Open Access | Times Cited: 115
Showing 1-25 of 115 citing articles:
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 177
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 177
Tumour-infiltrating lymphocytes: from prognosis to treatment selection
Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 3, pp. 451-458
Open Access | Times Cited: 133
Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, et al.
British Journal of Cancer (2022) Vol. 128, Iss. 3, pp. 451-458
Open Access | Times Cited: 133
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 100
A DNA/DMXAA/Metal–Organic Framework Activator of Innate Immunity for Boosting Anticancer Immunity
Xiaojing Chen, Qianyun Tang, Jinqiang Wang, et al.
Advanced Materials (2023), pp. 2210440-2210440
Closed Access | Times Cited: 51
Xiaojing Chen, Qianyun Tang, Jinqiang Wang, et al.
Advanced Materials (2023), pp. 2210440-2210440
Closed Access | Times Cited: 51
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Ornella Urzì, Roberta Gasparro, Elisa Costanzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12046-12046
Open Access | Times Cited: 51
Ornella Urzì, Roberta Gasparro, Elisa Costanzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12046-12046
Open Access | Times Cited: 51
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 47
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 47
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 44
Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
Kamilla J. A. Bigos, Conrado Guerrero Quiles, Sapna Lunj, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 27
Mn2+/CpG Oligodeoxynucleotides Codecorated Black Phosphorus Nanosheet Platform for Enhanced Antitumor Potency in Multimodal Therapy
Kai Ling, Jintao Zheng, Xiaohong Jiang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 2841-2860
Closed Access | Times Cited: 19
Kai Ling, Jintao Zheng, Xiaohong Jiang, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 2841-2860
Closed Access | Times Cited: 19
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
Bayley McRitchie, Billur Akkaya
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Bayley McRitchie, Billur Akkaya
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Nanomaterials: small particles show huge possibilities for cancer immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
“Find-eat” strategy targeting endothelial cells via receptor functionalized apoptotic body nanovesicle
Shutong Qian, Jiayi Mao, Qiuyu Zhao, et al.
Science Bulletin (2023) Vol. 68, Iss. 8, pp. 826-837
Closed Access | Times Cited: 32
Shutong Qian, Jiayi Mao, Qiuyu Zhao, et al.
Science Bulletin (2023) Vol. 68, Iss. 8, pp. 826-837
Closed Access | Times Cited: 32
Impaired function of dendritic cells within the tumor microenvironment
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Targeting the metabolism of tumor-infiltrating regulatory T cells
Yiming Wang, Tianning Huang, Jian Gu, et al.
Trends in Immunology (2023) Vol. 44, Iss. 8, pp. 598-612
Open Access | Times Cited: 23
Yiming Wang, Tianning Huang, Jian Gu, et al.
Trends in Immunology (2023) Vol. 44, Iss. 8, pp. 598-612
Open Access | Times Cited: 23
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
Na Song, Kai Cui, Liqun Zeng, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176357-176357
Closed Access | Times Cited: 16
Na Song, Kai Cui, Liqun Zeng, et al.
European Journal of Pharmacology (2024) Vol. 967, pp. 176357-176357
Closed Access | Times Cited: 16
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 16
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 16
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Kaina Chen, Timothy Wai Ho Shuen, Pierce K. H. Chow
British Journal of Cancer (2024) Vol. 131, Iss. 3, pp. 420-429
Open Access | Times Cited: 15
Kaina Chen, Timothy Wai Ho Shuen, Pierce K. H. Chow
British Journal of Cancer (2024) Vol. 131, Iss. 3, pp. 420-429
Open Access | Times Cited: 15
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 14
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 14
A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer
Xuanwen Bao, Qiong Li, Chen Dong, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101399-101399
Open Access | Times Cited: 14
Xuanwen Bao, Qiong Li, Chen Dong, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101399-101399
Open Access | Times Cited: 14
Translational research on drug development and biomarker discovery for hepatocellular carcinoma
Valerie Chew, Chien-Huai Chuang, Chiun Hsu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10
Valerie Chew, Chien-Huai Chuang, Chiun Hsu
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 10
The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions
Tianqi Zhang, Qianyu Lv, Weilin Jin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189137-189137
Closed Access | Times Cited: 9
Tianqi Zhang, Qianyu Lv, Weilin Jin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189137-189137
Closed Access | Times Cited: 9
Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 9
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 9
Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
Shabnam Eghbali, Thatcher Heumann
Cancers (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access | Times Cited: 1
CCL20/CXCL5 Drives Crosstalk Between Anaplastic Thyroid Cancer Stem Cells and Tumor‐Associated Macrophages to Promote Tumor Progression
Qi Liu, Yan Wang, Mingyuan Song, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Qi Liu, Yan Wang, Mingyuan Song, et al.
Advanced Science (2025)
Open Access | Times Cited: 1